A detailed history of Advisor Group Holdings, Inc. transactions in Volitionrx LTD stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 4,400 shares of VNRX stock, worth $2,992. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,400
Previous 900 388.89%
Holding current value
$2,992
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.5 - $0.76 $1,750 - $2,660
3,500 Added 388.89%
4,400 $2,000
Q2 2024

Aug 13, 2024

SELL
$0.59 - $0.91 $17,180 - $26,499
-29,120 Reduced 97.0%
900 $0
Q1 2024

May 10, 2024

BUY
$0.72 - $1.19 $7,704 - $12,733
10,700 Added 55.38%
30,020 $22,000
Q4 2023

Feb 12, 2024

BUY
$0.55 - $0.88 $10,450 - $16,720
19,000 Added 5937.5%
19,320 $13,000
Q2 2023

Aug 10, 2023

SELL
$1.39 - $2.02 $278 - $404
-200 Reduced 38.46%
320 $0
Q4 2022

Feb 10, 2023

SELL
$1.39 - $2.6 $14,316 - $26,780
-10,300 Reduced 95.19%
520 $1,000
Q3 2022

Nov 14, 2022

BUY
$1.36 - $2.38 $1,224 - $2,142
900 Added 9.07%
10,820 $14,000
Q2 2022

Aug 10, 2022

BUY
$1.96 - $3.05 $12,544 - $19,520
6,400 Added 181.82%
9,920 $20,000
Q1 2022

May 04, 2022

SELL
$2.41 - $3.24 $30,848 - $41,472
-12,800 Reduced 78.43%
3,520 $10,000
Q3 2021

Nov 05, 2021

SELL
$2.98 - $3.48 $3,278 - $3,828
-1,100 Reduced 6.31%
16,320 $51,000
Q2 2021

Aug 02, 2021

BUY
$3.01 - $3.78 $902 - $1,134
300 Added 1.75%
17,420 $58,000
Q1 2021

May 13, 2021

BUY
$3.33 - $6.5 $18,714 - $36,530
5,620 Added 48.87%
17,120 $65,000
Q4 2020

Feb 10, 2021

SELL
$2.88 - $4.33 $2,880 - $4,330
-1,000 Reduced 8.0%
11,500 $45,000
Q3 2020

Nov 12, 2020

SELL
$2.94 - $4.05 $85,260 - $117,450
-29,000 Reduced 69.88%
12,500 $40,000
Q2 2020

Aug 14, 2020

SELL
$2.89 - $4.32 $42,685 - $63,806
-14,770 Reduced 26.25%
41,500 $162,000
Q1 2020

May 18, 2020

BUY
$2.47 - $5.16 $138,986 - $290,353
56,270 New
56,270 $176,000

Others Institutions Holding VNRX

About VOLITIONRX LTD


  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $39M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.